Among all enriched disease terms at FDR 5% (Fig 5A), many of them are well-supported in the literature such as enrichment of Type-2 Diabetes for Insulin [51], breast cancer for progesterone [52], and colorectal cancer for somatotropin [53]. This evidence concerns the gene INS and breast carcinoma.